Company Filing History:
Years Active: 2025
Title: Prince Bhebe: Innovator in Antibody Glycoform Control
Introduction
Prince Bhebe is a notable inventor based in Moorpark, CA (US). He has made significant contributions to the field of biotechnology, particularly in the modulation of glycoforms of antibodies. His innovative work has implications for the production of therapeutic proteins.
Latest Patents
Prince Bhebe holds a patent titled "Control of total afucosylated glycoforms of antibodies produced in cell culture." This patent outlines methods for modulating the levels of total afucosylated (TAF) glycoforms of recombinant glycosylated proteins produced by glycosylation-competent cells in a cell culture. The methods involve maintaining the cell culture at an initial set point pH for an initial cell culture period. Additionally, the patent includes related compositions comprising glycosylated proteins and TAF glycoforms.
Career Highlights
Prince Bhebe is currently employed at Amgen Inc., a leading biotechnology company. His work at Amgen focuses on advancing the understanding and production of glycosylated proteins, which are crucial for developing effective therapeutic agents.
Collaborations
Prince collaborates with talented coworkers, including Chung-Jr Huang and Madiha Khurshid. Their combined expertise contributes to the innovative research and development efforts at Amgen.
Conclusion
Prince Bhebe's contributions to the field of biotechnology, particularly in the control of antibody glycoforms, highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic protein production.